Michael S K, Brennan J, Robertson E J
Department of Molecular and Cellular Biology, Harvard University, Divinity Avenue, Cambridge, MA 02138, USA.
Mech Dev. 1999 Jul;85(1-2):35-47. doi: 10.1016/s0925-4773(99)00052-0.
Site specific recombinases have provided the experimental strategy necessary to modulate the expression of gene products in the mouse embryo. In this study we have exploited Cre recombinase to develop a widely applicable cell marking system which functions efficiently even at early post-implantation embryonic stages. Importantly, the techniques and reagents derived in this study are generally applicable to any recombinase driven approach, including strategies to temporally and spatially modulate endogenous or ectopic gene expression in the embryo. The cell marking scheme has two essential components which were derived as separate mouse lines. The first line carries a universal conditional lacZ reporter (UCR) locus which was prepared by using gene targeting in a novel approach to modify a ubiquitously expressed retroviral lacZ promoter trap insertion. The UCR locus is silent until it undergoes a Cre mediated DNA rearrangement to restore lacZ expression. To generate the Cre expressing allele, we outline a flexible strategy which requires the introduction of a novel IRES-Cre cassette into exon sequence of an endogenous locus by gene targeting. We successfully demonstrate this approach by generating a Cre expressing allele of the EphA2 gene, an Eph receptor protein tyrosine kinase expressed early in development. Analysis of double heterozygote embryos clearly demonstrates that Cre recombinase is expressed in vivo from the EphA2 IRES-Cre allele, and that the conditional reporter locus is efficiently restored in EphA2-expressing cells as early as 7.5 dpc. This cell marking experiment establishes the feasibility of expressing Cre recombinase from a single copy allele in the embryo and demonstrates the utility of the conditional reporter mouse which can be used in the analysis of any Cre expressing allele.
位点特异性重组酶为调控小鼠胚胎中基因产物的表达提供了必要的实验策略。在本研究中,我们利用Cre重组酶开发了一种广泛适用的细胞标记系统,该系统即使在植入后早期胚胎阶段也能高效发挥作用。重要的是,本研究中获得的技术和试剂通常适用于任何重组酶驱动的方法,包括在胚胎中时空调控内源性或异位基因表达的策略。细胞标记方案有两个基本组成部分,它们分别作为独立的小鼠品系获得。第一个品系携带一个通用条件性lacZ报告基因(UCR)位点,该位点是通过基因靶向以一种新颖的方法制备的,用于修饰一个普遍表达的逆转录病毒lacZ启动子捕获插入。UCR位点在经历Cre介导的DNA重排以恢复lacZ表达之前是沉默的。为了产生表达Cre的等位基因,我们概述了一种灵活的策略,该策略需要通过基因靶向将一个新的IRES-Cre盒引入内源性位点的外显子序列。我们通过产生EphA2基因的表达Cre的等位基因成功证明了这种方法,EphA2是一种在发育早期表达的Eph受体蛋白酪氨酸激酶。对双杂合子胚胎的分析清楚地表明,Cre重组酶在体内从EphA2 IRES-Cre等位基因表达,并且条件性报告基因位点早在胚胎发育7.5天就可以在表达EphA2的细胞中有效恢复。这个细胞标记实验确立了在胚胎中从单拷贝等位基因表达Cre重组酶的可行性,并证明了条件性报告基因小鼠在分析任何表达Cre的等位基因中的实用性。